Manisha Pai

Public Communications Contact at VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

Consumer Services

Profile

Manisha Pai is currently working as an Executive Director-Investor Relations at Vertex Pharmaceuticals, Inc. Prior to this, she worked as Head-Public Relations at Millennium Pharmaceuticals, Inc. from 2008 to 2013, and then as Head-Public Relations at Pharmacyclics LLC from 2013 to 2014.
From 2014 to 2015, she worked as Head-IR & Corporate Communications at Epizyme, Inc. and from 2015 to 2017, she worked as Head-IR & Corporate Communications at bluebird bio, Inc. She is also a former Vice President-Investor Relations & Communications at Magenta Therapeutics, Inc. Ms. Pai completed her undergraduate degree from Amherst College.

Manisha Pai active positions

Companies	Position	Start
VERTEX PHARMACEUTICALS INCORPORATED	Public Communications Contact	-

All active positions of Manisha Pai

Former positions of Manisha Pai

Companies	Position	End
BLUEBIRD BIO, INC.	Investor Relations Contact	01/10/2017
EPIZYME, INC.	Investor Relations Contact	01/04/2015
PHARMACYCLICS, INC.	Corporate Officer/Principal	01/01/2014
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/07/2013
MAGENTA THERAPEUTICS	Investor Relations Contact	-

See the detail of Manisha Pai's experience

Training of Manisha Pai

Amherst College

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Manisha Pai's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
BLUEBIRD BIO, INC.	Health Technology
VERTEX PHARMACEUTICALS INCORPORATED	Health Technology

Private companies	4
Epizyme, Inc. Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA.	Health Technology
Magenta Therapeutics, Inc. Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA.	Health Technology
Pharmacyclics LLC Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA.	Health Technology
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.	Health Technology

See company connections